发明名称 |
MONITORING IMMUNE RESPONSIVENESS TO CANCER VACCINATION |
摘要 |
<p>The invention is direct to a method for determining a cancer patient's immune responsiveness to anti-cancer vaccination. In one aspect, for each of a plurality of vaccinations, pairs of clonotype profiles are obtained, one immediately prior to vaccination and one during the period of peak immune response, usually within two to twenty days after the vaccination. Responsiveness is correlated to successive increases in identical clonotypes within each pair of clonotype profiles in at least two successive vaccinations.</p> |
申请公布号 |
WO2013134302(A1) |
申请公布日期 |
2013.09.12 |
申请号 |
WO2013US29181 |
申请日期 |
2013.03.05 |
申请人 |
SEQUENTA, INC.;FAHAM, MALEK;KLINGER, MARK |
发明人 |
FAHAM, MALEK;KLINGER, MARK |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|